Featured Research

from universities, journals, and other organizations

Next generation vaccines: Eliminating the use of needles

Date:
October 23, 2012
Source:
Royal Holloway, University of London
Summary:
Scientists have developed a pioneering new method of oral vaccination which could help boost immunity to tuberculosis (TB) and influenza, as well as prevent C. difficile for which there is currently no vaccine.

Scientists at Royal Holloway, University of London have developed a pioneering new method of oral vaccination which could help boost immunity to tuberculosis (TB) and influenza, as well as prevent C. difficile for which there is currently no vaccine.

Lead scientist Professor Simon Cutting, from the School of Biological Sciences at Royal Holloway, has developed the jabs through the use of probiotic spores. He carried out fundamental studies into the biology of the bacterium Bacillus subtilis which attracted the attention of microbiologists due to its ability to form spores that can last millions of years before germinating under the appropriate environmental conditions.

Professor Cutting says: "The mechanisms by which this process occurs have fascinated microbiologists for decades making it one of the most intensively studied bacteria. Its simple life cycle and ease of use make it an ideal laboratory subject."

Professor Cutting discovered that the Bacillus spores act as ideal vehicles to carry antigens and promote an immune response. He explains: "Rather than requiring needle delivery, vaccines based on Bacillus spores can be delivered via a nasal spray, or as on oral liquid or capsule. Alternatively they can be administered via a small soluble film placed under the tongue, in a similar way to modern breath freshners. As spores are exceptionally stable, vaccines based on Bacillus do not require cold-chain storage alleviating a further issue with current vaccine approaches."

As well as eliminating the pain associated with needles, oral vaccines provide greater benefits including being safer to administer, especially in developing countries where HIV is rife, being inexpensive to produce and easier to store and reducing concerns of adverse reactions.

Professor Cutting has carried out pre-clinical evaluation of Bacillus-based vaccines for a number of diseases including Tuberculosis, influenza and tetanus but most recently he has been investigating the potential for use of the vaccines against a disease of particular relevance to the West -- Clostridium difficile

"C. difficile, is a gastrointenstinal infection that is commonly picked up following hospital stays and causes around 50,000 infections and 4,000 deaths per year in the UK, mostly in elderly patients. Currently, there is no vaccine against the disease, and although several approaches are currently undergoing clinical trials, none are expected to provide full protection, and new solutions are urgently needed," says Professor Cutting.

He adds: "Bacillus based vaccines offer distinct advantages as unlike other approaches, oral delivery can cause a more specific immune response in the gastrointenstinal tract to fully eliminate C.difficile."

Professor Cutting has recently received private seed investment to form a company, Holloway Immunology, to develop the bacillus vaccine technology and concentrate on three lead vaccines for Tuberculosis, C. difficile infection and influenza (flu). The company is currently looking for investors to help fast track the implementation of these jabs and contribute to the transformation of vaccine delivery around the globe.


Story Source:

The above story is based on materials provided by Royal Holloway, University of London. Note: Materials may be edited for content and length.


Cite This Page:

Royal Holloway, University of London. "Next generation vaccines: Eliminating the use of needles." ScienceDaily. ScienceDaily, 23 October 2012. <www.sciencedaily.com/releases/2012/10/121023090836.htm>.
Royal Holloway, University of London. (2012, October 23). Next generation vaccines: Eliminating the use of needles. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2012/10/121023090836.htm
Royal Holloway, University of London. "Next generation vaccines: Eliminating the use of needles." ScienceDaily. www.sciencedaily.com/releases/2012/10/121023090836.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins